OKLAHOMA CITY– LifeShare of Oklahomathe state organization responsible for the recovery of organs and tissues for transplantation, made national history by being the first organ procurement organization (OPO) in the United States to own, operate and successfully place a liver for transplantation after preservation on the OrganOx meter.
This is the first time a liver has been clinically transplanted in the United States after being preserved on the metra by a preservation team based at the OPO.
Previously, all US transplants involving the device were performed by transplant center teams as part of the clinical trial or after Food and Drug Administration (FDA) approval.
LifeShare has its own in-house team of specially trained technicians who operate the infusion set. Perfusion is defined as the passage of a liquid through the lymphatic system or blood vessels to an organ or tissue.
Oklahoma’s OPO initially began using this new infusion technology to conduct clinical research before the device was approved by the FDA for use in transplants.
According to the press release, organ perfusion and preservation has become a heavily explored area of medical advancement in hopes of providing more organs for transplant to reduce the national waiting list.
Over the years, LifeShare has developed its use of perfusion technology to improve both the number and quality of organs available for transplantation with an emphasis on kidney and liver preservation.
“When we started down this path to expand our liver preservation efforts last November, the vision was to bring this important and vital new technology to LifeShare to continue our mission to save more lives,” said Jeffrey Orlowski, President and CEO of LifeShare. . “We are pleased to report that our vision has become a reality with our preservation team placing a liver for transplant after it was infused with metra.”
This announcement follows the opening by LifeShare of a new Clinical Innovation Center in April, which houses the organization’s tissue recovery and organ preservation efforts.
The Clinical Innovation Center is a new, state-of-the-art, 19,000 square foot clinical facility built to support LifeShare’s primary goal of saving and healing lives, as well as medical advancements in donation and transplantation, the statement said. .
“The work LifeShare is doing is a major step forward in liver preservation,” Orlowski said. “Our work is proof that an OPO-based liver perfusion system can be successfully implemented, expanding efforts to save more lives across the country.”
LifeShare works closely with three transplant centers and 145 healthcare organizations in the state of Oklahoma to facilitate donation. The organization strives to raise public awareness of organ, eye, and tissue donation and transplantation through public education.
For more information about LifeShare of Oklahoma, visit lifeshareoklahoma.org.